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Abstract 
Background: Since the first case of Coronavirus Disease 2019 (COVID-19) in Italy, all the hospital 
facilities had to reform their daily activities. Amidst them, the Interventional Radiology Department in 
the “Azienda Ospedaliera Universitaria” of Novara (Italy) had to create a dedicated protocol for the 
patent’s management during the pandemic. 
Design and Methods: The time interval between February 2020 and March 2021 was divided into 
three different periods and we reported the evolution of our safety protocol, the changes in our daily 
activities and the rates of SARS-CoV-2 infection among the healthcare workers (HCW) of the 
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Angiographic Suite. Personnel who had positive partners/family members or who had established 
close contacts of another nature outside the workplace were excluded from the study, in order to 
reduce any bias. 
Results: A total of 35 HCWs served in 355 patient procedures on SARS-CoV-2 positive patients from 
February 2020 to March 2021. During the year there was a reduction in the morbidity rate first from 
7.9% to 1.4% and then currently reaching 0%. 
Conclusions: Dedicated routes, elevators, establishing Filter Areas and a clear demarcation between 
clean and contaminated areas, Dressing and undressing procedures, Cleaning procedures and the 
obligation to always wear a surgical mask during the working shift are essential to prevent in-hospital 
infection. The vaccines’ arrival seems to further reduce the risk for healthcare workers, but it is still 
necessary to take docile precautions in view of the new mutations of the virus. 
 
Significance for Public Health 
During the last year, about 3.26 million infections for SARS-CoV-2 have occurred in Italy. 
Interventional Radiology has been placed in the second line due to its irreplaceable urgency activity 
(e.g. stroke and arterial bleeding). Currently, we are facing a new wave of infections, which, unlike the 
previous ones, is part of an active vaccination campaign on the population. Furthermore, the arrival of 
new SARS-CoV-2 mutant strains such as United Kingdom, South African and Brazilian variants, show 
different rates of virulence and contagion capacity. Through this study, a management model of the 
Angiographic Suite (aimed at the protection of personnel and for patient management) is proposed to 
face the new airborn pandemic. This protocol could be a precious hint for further and institutional 
regarding public health measures. 
 
Introduction 
In December 2019, in Wuhan, Hubei Province, China a cluster of patients with pneumonia of unknown 
cause were hospitalized (1). The cause was later found out to be SARS-CoV-2, and it soon became an 




The main aim was to grant the continuous radiologic diagnostic and interventional assistance for the 
whole healthcare emergency, assuring the safety for the staff and both infected and un-infected 
patients (2). 
Within the Radiology Department, the Interventional Radiology (IR) staff (radiologists, nurses and 
radiographers), being in close contact with patients were the most at-risk category (3). 
In order to provide continuity to the interventional service in full safety, changes to patient 
management protocols and organization inside the angiographic suite were necessary. 
We had different problems to address: environmental issues, cleaning and disinfection procedures, 
personnel formation, organization inside the angiographic suite, operating room daily routine with 
patient selection through rapid/molecular swabs. 
Since the beginning of the SARS-CoV-2 pandemic, the main tools to detect the presence of SARS-CoV-
2 were molecular swabs, antibodies tests and more recently the rapid antigenic swab tests. The most 
used test is the molecular swab test, with an overall sensitivity of 94% (95% confidence interval 86 to 
98) and an overall specificity of 100% (99 to 100)(4). The rapid Ag swab is the latest tool introduced 
that played a significant role in surveillance of COVID-19.  Rapid Diagnostic Test Ag-RDTs correctly 
identify more cases than what they miss (sensitivity ≥80%) and have very high specificity (≥97-100%) 
(5). Antibodies detected in serum are used to investigate the immunity state. A cumulative sensitivity 
of 82% for IgM, and 85% for both IgG and total antibodies. Pooled specificity was 98% for IgM and 
99% for both IgG and total antibodies (6). 
In Italy, the vaccination program was introduced on 27th December 2020. The first available vaccination 
was Pfizer-BioNTech COVID-19, that consists of two doses (30 μg, 0.3 mL each) administered 
intramuscularly, three weeks apart. Polack et al., in a clinical trial, reported that the Pfizer-BioNTech 
COVID-19 vaccine was 95.0% effective (95% confidence interval = 90.3%–97.6%) in preventing 
symptomatic laboratory-confirmed COVID-19 in people without evidence of previous SARS-CoV-2  
infection (7). Consistent high efficacy (≥92%) was observed across age, sex, race, and ethnicity 
categories and among people with underlying medical conditions. Efficacy was similarly high in a 
secondary analysis including participants both with or without evidence of previous SARS-CoV-2  
infection (7). 
Last data found in literature show that the seroprevalence of SARS-CoV-2  in Italy is closer to 7-8%. 
(8). By now, in Italy 2.003.391 have been vaccinated, and 572252 doses were given in Piedmont (9). 
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The aim of this study is to describe the evolution of the protocol, the one currently in use in our 
interventional radiology department and the infection ratio among our healthcare workers. 
  
Design and Methods 
To evaluate the effect of the protocol in use, we described the number of SARS-CoV-2 infection 
among our employees. The study period from February 2020 to March 2021 was separated in three 
time-range: from February 2020 to April 2020 (COVID-19 breakout period or period 1), from May 
2020 to December 2020 (COVID-19 steady period or period 2) and from January 2021 to March 2021 
(COVID-19 Vax period or period 3). Every patient was considered as positive if one of more of these 
criteria were present at the moment of the angiographic procedure:  
• Suggestive clinical symptoms (high temperature over 37.5°C, cough more than 3-day, dyspnea) 
(10). 
• COVID-19 related - CT findings classified as “indeterminate appearance” or “typical 
appearance”, according to RSNA consensus statement (11).  
• Positive molecular swab (from the second half of March 2020) and/or positive rapid swabs 
(from July 2020) (12). 
The HCWs are considered positive if the monthly screening swab or the swabs for flu-like symptoms 
found positivity vs COVID-19 antigens. 
Personnel who had positive partners / family members (two HCWs) or who had established close 
contacts of another nature outside the workplace (one HCW) were excluded from the study, in order 




In order to protect both patients and the involved personnel, it was necessary re-organize all the 
working environment. According to literature, exposure sources to SARS-CoV-2 are various. The main 
two are through droplets and through direct or indirect contact(13). 
Moreover, the virus can spread through aerosol in certain conditions, for example during intubation 
and in all the maneuvers involving the upper airways (14,15).  
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Our angiographic suite is located in a different block than the emergency room and all the other 
departments who were being set up to host the COVID-19 positive patients.  
We only have two angiographic suites but none of them had a filter area between “clean” and 
“contaminated” areas. Each operating unit had to be arranged in progressively less contaminated 
areas, from the reception area to the operating theatres. Following this principle, in order to treat this 
type of patients we had to set up and build a separate room before entering the angiographic suite, to 
be used mainly for undressing and keeping the used Personal Protective Equipment (PPE) that has to 
be thrown away or disinfected for reuse. 
Trolleys, and all the non-essential equipment have been moved in the “clean” area. Ventilators, 
pedalboard, mattress, C-arm have all been protected and covered with disposable plastic hoods. At 
the end of each procedure all these are disposed by a dedicated cleaning crew. 




The protocol in use was taught to all HCWs. Each time a patient is treated we establish who is the 
“clean” and the “contaminated” healthcare personnel, which has to stay under a 1.5m distance from 
patients. The latter, after entering the “SARS-CoV-2” area, cannot go out without a dedicated 
undressing procedure. 
Routinely, the medical staff wears surgical masks at all times during their working shift (3). The 
dressing procedure is started before patient’s arrival in order to be able to attend to his needs as soon 
as he arrives. 
We used the hospital’s protocol for dressing and undressing procedures, but we had to add a few 
modifications in order to fit the lead aprons (Fig. 1 & Fig.2).  
Dressing procedure 
Wear in Order: 
Make sure not to wear jewellery and tie hair 
• Wear Lead apron 
Perform hand hygiene 





• Long OverBoots 
Second Hand Hygiene 
• Sterile Coat 
• Long sleeved Gloves 
• Short Gloves 
For Surgeons only after the patients has entered. 
• Sterile Coat and sterile Gloves 
Undressing procedure 
It needs someone (wearing PPE) helping from outside with a pack of short gloves and sodium 
hypochlorite spray for hand hygiene. 
Remove in Order, without making sudden moves and throwing everything inside the bin cautiously 
to avoid spreading of droplets. 
For Surgeons – Sterile Coat and Gloves 
• Short Gloves and Sterile Coat simultaneously  
Hand Hygiene 
• - Wear clean disposable Short Gloves 
• Remove Goggles and place them in the appropriate container for cleaning. Spray them with 
sodium hypochlorite. 
• Remove cap 
• Remove over boots- when doing so, exit one step at a time out of the “Dirty” Area. 
• Short Gloves 
Hand Hygiene 
• - Wear disposable Short Gloves 
• Remove FFP2 mask 
 
The mask in use are the FFP2, which have a high filter capacity (closer to 94%) (3) 
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While the dressing procedures can be performed by a single person, a dedicated colleague checks 
that the procedure is followed correctly, in order to prevent mistakes. 
Dressing and undressing procedures were taught in a short training session in classes of four people 
lasting about 30 minutes.  
Surgical masks always must be worn during working shifts. Healthcare providers with flu-like 
symptoms should refrain from coming to the workplace as not to infect healthy patients. 
 
Cleaning and disinfection procedure 
All equipment used for interventional radiology maneuvers inside the operating room is covered with 
plastic sheets and dedicated disinfection must be done after every patient. 
All the corridors leading to the operating rooms need their access to be restricted and then 
disinfected after the passage of the patient in order to reduce droplet spread.   
Our standard cleaning procedure involves the use of sodium hypochlorite and a quaternary 
ammonium compound for the angiographic suite and the staff (18). 
Once the sanitization is over, radiographers take care of cleaning the C-Arm and electronic 
instrumentation as well as the HEPA filters when needed (using the appropriate PPEs). 
All the protective face masks are a single use device, and they don’t need a specific cleaning 
procedure. Clogs and any other PPE reusable are cleaned twice by their own users and placed in a 
tank with sodium hypochlorite. 
Until everything is done the operating room remains closed (est. duration 30 min). 
 
Organization inside the Angiographic Suite 
During airway management of patients who require emergent intubation there is a high risk of 
aerosol and droplets dissemination (14–16). Measures to protect the resuscitation equipment and 
mechanical ventilators are necessary. All non-essential catheterization tools, guidewires, needles, 
devices are removed from the angiographic suite, or covered with plastic sheets (Fig.3). Everything 
must be ready before the patient is brought to the Interventional room. Only essential personnel 
should be involved in the procedures at closed doors. If any device is needed from outside, a 
dedicated person, who is wearing PPE passes it through the filter area between the “clean” area and 




Angiographic Suite daily routine 
We regularly had to change patient selection criteria in order to abide by the Government rules 
regarding RT rates of infection in Piedmont. We went from treating only emergencies and oncologic 
patients during February-June, to returning to our normal routine until the second wave in October, 
when fewer procedures were allowed again. Measures in use keep changing as R number values vary 
over time. During the COVID-19 steady period, except for emergencies all patients were required to 
have a molecular negative swab test in order to access to treatments. 
All HCW must undergo monthly screening with molecular antigenic testing and are isolated at any 
sign of flu-like symptoms and tested if come in contact with anyone infected. 
At the beginning of the pandemic not every patient underwent a throat swab for SARS-CoV-2, as they 
were not readily available, and sometimes we got to know about their infection accidentally from 
chest CT-scan. From July we have been doing regular molecular testing on Hospital arrival and rapid 
antigenic test in order to admit patients to the angiographic suite. In emergencies if patients are 
positive to the antigenic test, but the molecular test results are not yet available, we treat patients as 
if they were positive, as we have initially found out discrepancies between the tests in our earlier 
experience, and to maximize HCW protection. The implementation of all safety protocol throughout 
the Hospital, all personnel formation took from the end of February 2020 until April 2020. From May 
2020 till December 2020 on we continued with this protocol. 
At the beginning of the COVID-19 vax period, we witnessed an increase in the Italian territory of viral 
mutants, including United Kingdom and South Africa. Currently the protocol has abolished the use of 
rapid tests and patients are considered negative only in the presence of a molecular test result. 
 
Vax schedule 
From the 20th of December 2020, the Pfizer-BioNTech vaccine program started for all the personnel, 
achieving immunity with the double dose of vaccine at the second week of January 2021. No serologic 
test has been performed to evaluate the acquired immunity. The HCW that had COVID-19 in the past 
months has been vaccinated too, in according with the Ministry of Health recommendations (9). 





A total of 355 SARS-CoV-2  positive patients were treated from February 2020 to March of 2021 
(period 1-2-3). Mostly emergencies - 88 (25.1%) strokes procedures, 134 (38.3%) embolizations for 
arterial bleeding, 104 (29.7%) Acute Limb Ischemias, 24 (6.9%), different planned procedures such as 
Acute ruptured Cerebral Aneurismal Embolizations, superior mesenteric artery acute ischemias, 
biliary drainage positioning, suppurative collection drainages, cholecystostomies as shown in Table 1. 
Thirty-five out of thirty-eight HCWs satisfied the inclusion criteria.  
From February 2020 to April 2020, 63 procedures (the 18% of 355) were performed in the 
angiographic suite. In this period, five of the 35 HCWs, resulted positive to SARS-CoV-2  (morbidity tax 
of 14,3%). From May 2020 to December 2020, we implemented our Safety Protocol. In this period, on 
a total of 216 procedures (61,7%), only three HCWs resulted positive (morbidity rate of 8.6%). Since 
the vaccine in January, no HCWs resulted positive (morbidity rate of 0%). The ratio between HCWs 
infected and procedures number is about 7.9% (5 infected on 63 procedures) for the period 1 (COVID-
19 breakout period), about 1.4% (3/216) for the period 2(COVID-19 steady period) and about 0% 















Stroke 27 50 11 
Bleeding 17 91 26 
Acute ischemic 
limb 
17 60 27 
Other 2 15 7 
Total 63 216 71 
Infected HCW 5/35 3/35 0/35 
Table 1: Number of procedures on COVID-19 positive patients and HCWs Infected before the 




Despite the regulations that the Italian and European governments have implemented to contain the 
COVID-19 pandemic, we are witnessing a new increase in positive cases as for the beginning of a new 
wave of infections (19,20). In the last year, we have seen the development of different technologies 
such as rapid antigen swabs and, more recently, the worldwide launch of several highly effective 
vaccines (7,21–23). 
The aim of the study is to describe the evolution of the management protocol of the angiographic 
suite and the number of infected among the healthcare workers in the three periods that 
characterized the pandemic caused by the Sar-Cov-2 virus: COVID-19 breakout period (period 1, 
February 2020 to April 2020), COVID-19 steady period (period 2, May 2020 to December 2020) and 
COVID-19 Vax period (period 3, January 2021 to March 2021). 
Of these time intervals, the COVID-19 steady period (period 2) is the largest and with approximately 
three times the number of procedures performed on COVID-19 positive patients.  
Despite the high number of interventions carried out on infected patients, the infection rate among the 
HCW was lower than in the period 1, the COVID-19 breakout period (1.4% vs 7.9%). The modification 
of the angiographic suite management protocol, which took place after the introduction of molecular 
swabs, allowed for a better classification of patients with consequent better management of cases. The 
latest update of the COVID-19 patient management protocol in angiographic suite improved the 
vaccination’s awareness. Among our personnel, the vaccine adherence rate was 100%. Although the 
number of procedures on COVID-19 positive patients, between the period 1 and the period 3 (the 
current one), did not substantially change (63 vs 71 procedures, respectively), no operator has been 
infected since January.  
Compared to the main protocols reported in the literature (17,24–27) regarding patient management 
in the angiographic suite, no substantial differences in patient management are reported. However, 
to our knowledge, no proposals for updated protocols have been found for vaccinated personnel and 
for COVID-19 mutant variants. 
In Literature, there isn’t enough evidence on the effectiveness of vaccination using Pfizer BioNTech 
(administered at 100% of the HCWs) in the COVID-19 variants. Particularly, Xuping et al. reported a 
similar efficacy of BNT162b2 vaccine (Pfizer) in United Kingdom and South African variants. However, 
the article concludes with the necessity to confirm the vaccine effectiveness against variant viruses 
with further clinical data (28). Moreover, Madhi et al. reports the Oxford/Astrazeneca efficacy of 
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10.4% against the South African variant B.1.351 (29) . For this reason, our center has chosen to keep a 
strict protocol, without reducing the protection standards for patients who result or wait for 
molecular swab’s results.  
Further studies are required to increase the degree of evidence about the safety of this protocol. 
Multicenter studies are recommended, both retrospective and prospective, combined using a 
common protocol.  
Particular attention should be paid to controlling any biases as the possibility of an outer source of 
out-of-hospital infection and/or the possibility of new viral mutants. 
 
Conclusions 
Interventional Radiology (IR) is an essential service for the population, delivering minimally invasive 
care for patients both in emergency and elective procedures. Even during the SARS-CoV-2 pandemic 
these procedures should not be delayed. 
Safety protocols are a mandatory means to protect HealthCare Workers. The presence of dedicated 
routes for infected patients, PPEs, cleaning protocols are as important as personnel training to avoid 
any risk of infection and guarantee continuity of care. 
The arrival of the vaccine seems to further reduce the risk for healthcare workers.  
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Fig.3 Angiographic room prepared with plastic covers on monitors, ventilator, X-Ray detector and lead 
protection 
 
 
